Real-world effects of hyoscine butylbromide combined with paracetamol in women with dysmenorrhea: a patient survey
These findings confirm the efficacy and tolerability data on PLUS from randomized controlled trials in a larger group of women conducting self-management of their dysmenorrhea in a real-world setting. Future studies should compare PLUS to other non-prescription treatments.
Authors
- Kathrin Stewen
- Harald Weigmann
- Roxana Schwab (ORCID: https://orcid.org/0000-0002-1489-0011)
- Selina Miehle
Institutions
- Johannes Gutenberg University Mainz (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Sanofi (Germany) (DE)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-04-14
- DOI
- https://doi.org/10.3389/fmed.2025.1581059
- Citations
- 2
- Primary Topic
- Menstrual Health and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.76
Funders
- Sanofi